Congress quietly tightens Medicaid asset tests, forcing hundreds of thousands off coverage

What it does

This bill requires all states to apply asset tests (checking how much money and property applicants own) to everyone applying for or receiving Medicaid, and to verify those assets electronically. Currently, asset tests apply only to elderly, blind, and disabled applicants in some states. The bill also requires states to report annually to Congress on how many people lose Medicaid due to asset limits, and gives the federal government power to penalize states that don't comply.

Why we flagged it

The bill's core function is to narrow Medicaid eligibility by imposing asset tests on all applicants, not just elderly/blind/disabled populations. This is a coverage-reduction measure disguised as an 'asset verification' or 'safeguarding' measure.

What the text implies

• Asset limits will force beneficiaries to spend down savings before qualifying, reducing financial security and emergency resilience for low-income families.
• The bill's 2-year phase-in and state reporting requirements create a federal tracking system to measure how many people are disenrolled, potentially setting a baseline for future coverage cuts.
• States with higher asset limits (some allow $15,000+) will face federal pressure to harmonize downward to SSI limits (~$2,000), eliminating state flexibility.
• Electronic asset verification may flag vehicles, home equity, or retirement accounts, disqualifying working families who appear 'too wealthy' on paper despite low income.

Who it affects

The bill will cause hundreds of thousands of working-age adults and families to lose Medicaid coverage because their assets (savings, vehicles, homes) exceed federal limits, even if their income qualifies them. This shifts healthcare costs from government to individuals and families, disproportionately harming low-income people who rely on Medicaid.

Who stands to gain

• pharmaceutical companies (reduced Medicaid volume but higher prices for remaining covered patients)
• private health insurers (potential shift of Medicaid enrollees to uninsured or underinsured status)
• healthcare providers (reduced uncompensated care burden, but offset by increased uninsured patient v

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Social Security Administration (SSI), Department of Health and Human Services (HHS), Bristol Myers Squibb (BMY), Guardant Health (GH), Pfizer (PFE), DaVita (DVA), Johnson & Johnson (JNJ), Puerto Rico, Virgin Islands, Guam, Northern Mariana Islands — and 1 more

Where it stands

10 cosponsors: 10 Republicans.

• Mar 14, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Mar 14, 2025 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance. (text: CR S1778-1779)”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,520,000 in lobbying spend. A filing names 2 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

John Barrasso, the sponsor, reported $408,500 in PAC receipts in the 2026 cycle.

• Relx Inc — $1,520,000 on 2 filings

Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.